23.1 Non-current financial and other assets
23.2 Current financial and other assets
23.3 Financial assets at fair value through other comprehensive income (FVOCI)
The current and non-current financial assets at FVOCI (excl.
23.4 Investment in associates
In December 2017, the Group made an investment in Syndesi Therapeutics SA, a Belgian company. This investment was considered as an investment in an associate as UCB had significant influence via its equity holding and Board seat.
23.5 Joint operations
No joint operations were entered into by the Group in 2020.
23.6 Subsidiaries with material non-controlling interest
The accumulated non-controlling interest as of December 31, 2020 is € 1 million and relates to Edev S.à r.l. (“Edev”). No dividends have been paid to non-controlling interests during either 2020 or 2019.